These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 10316569)
21. Beware of new drugs, study suggests. Levenson D Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085 [No Abstract] [Full Text] [Related]
22. International research agreement leads to new U.S. guidelines. Maloney DM Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182 [No Abstract] [Full Text] [Related]
23. Relative drug safety and efficacy: any help for the practitioner? Rucker TD; Visconti JA Am J Hosp Pharm; 1979 Aug; 36(8):1099-101. PubMed ID: 484571 [TBL] [Abstract][Full Text] [Related]
24. Canadian drugs: panacea or problem? State Legis; 2004 Jun; 30(6):9. PubMed ID: 15179953 [No Abstract] [Full Text] [Related]
25. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption. Poser S Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225 [No Abstract] [Full Text] [Related]
26. RU 486 and the politics of drug regulation in the United States and France. Kramnick RK Cornell Int Law J; 1992; 25():667-718. PubMed ID: 11656340 [No Abstract] [Full Text] [Related]
27. Current trends in IND-NDA procedures. Brilhart KB Bull Parenter Drug Assoc; 1971; 25(3):132-9. PubMed ID: 5093249 [No Abstract] [Full Text] [Related]
28. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
29. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
30. Adverse drug reactions: a review for healthcare practitioners. Young LR; Wurtzbacher JD; Blankenship CS Am J Manag Care; 1997 Dec; 3(12):1884-906; quiz 1909-10. PubMed ID: 10178476 [No Abstract] [Full Text] [Related]
31. Expired drugs are not dead drugs. Torigian PC Am J Hosp Pharm; 1993 Mar; 50(3):448. PubMed ID: 8442459 [No Abstract] [Full Text] [Related]
32. Failures of the therapeutic chain as a cause of drug ineffectiveness. Figueras A; Laporte JR BMJ; 2003 Apr; 326(7395):895-6. PubMed ID: 12714454 [No Abstract] [Full Text] [Related]
33. Massachusetts city attempts to import drugs form Canada. Caroll J Manag Care; 2003 Oct; 12(10):16-7. PubMed ID: 14598537 [No Abstract] [Full Text] [Related]
34. Regulation of genetic modification of organisms: science or emotion? Malinowski MJ J Biolaw Bus; 1998; 1(3):3-7. PubMed ID: 11657280 [No Abstract] [Full Text] [Related]
35. The intensified drug inspection program: procedures and results. Clevenger WL Bull Parenter Drug Assoc; 1969; 23(6):263-8. PubMed ID: 5355888 [No Abstract] [Full Text] [Related]
36. Determining drug equality. Hecht A FDA Consum; 1975 Nov; 9(9):18-20. PubMed ID: 10316633 [No Abstract] [Full Text] [Related]
37. Food and drug administration. Simmons HE Pharmacology; 1972; 8(1):206-7. PubMed ID: 4678638 [No Abstract] [Full Text] [Related]
38. Keeping watch on drug quality. Furman WB FDA Consum; 1975 Oct; 9(8):18-23. PubMed ID: 10316632 [No Abstract] [Full Text] [Related]
39. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference. Enzi MB Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090 [No Abstract] [Full Text] [Related]
40. A timely re-examination of drug polymorphism in pharmaceutical development and regulation. Grant DJ; Byrn SR Adv Drug Deliv Rev; 2004 Feb; 56(3):237-9. PubMed ID: 14962580 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]